Elizabeth Budde, Laurie Sehn, Matthew Matasar, Stephen Schuster, Sarit Assouline, John Kuruvilla, Won-Seog Kim, Chan Cheah, Mazyar Shadman, Sascha Dietrich, Matthew Ku, Dima El-Sharkawi, Norma Gutierrez, Michael C. Wei, Shen Yin, Jason Sit, Samuel Tracy, Fidelis Sabalvaro, Elicia Peneul, Nancy Bartlett. "Fixed treatment duration mosunetuzumab continues to demonstrate clinically meaningful outcomes in patients with relapsed/refractory (R/R) follicular lymphoma (FL) after ≥2 prior therapies: 5-year follow-up of a pivotal Phase II study." Blood, 2025. doi:10.1182/blood-2025-5352